Who Makes Xphozah and Where to Direct Shelf Space Requests
Xphozah (atoltivimab/maftivimab/odesivimab), made by Hansoh Pharma for treating Ebola virus disease, is distributed through specialized channels due to its orphan drug status and limited market.[1] Contact Hansoh Pharma's commercial team directly via their U.S. operations at Hansoh Healthcare USA or through their parent company site (hansoh.cn/en) for allocation requests. For hospital or pharmacy shelf space, reach out to their supply chain partners like McKesson or Cardinal Health, listed on Hansoh's product resources.
How to Request Shelf Space from Wholesalers and Pharmacies
Major U.S. drug wholesalers handling specialty meds like Xphozah include:
- McKesson: Submit a stock increase request through their Provider Portal or call 800-482-6700, providing purchase history and demand forecasts.
- Cardinal Health: Use their StockView platform or contact specialty distribution at 800-926-3161, citing NDC 80420-100-01.
- AmerisourceBergen (Cencora): Log into PINPOINT or email [email protected] with projected volumes.
Pharmacies or hospitals: Email Hansoh's medical information at [email protected] with your facility details, current inventory, and justification (e.g., patient demand in Ebola high-risk areas). Expect NDA holder approval for expansions.[2]
What Influences Shelf Space Allocation for Orphan Drugs Like Xphozah
Shelf space for low-volume drugs depends on wholesaler contracts, FDA exclusivity (NDA approved Oct 2024), and demand data. Provide evidence like regional outbreak risks or VA/DoD contracts to prioritize. No generic competition exists yet; patent details available on DrugPatentWatch.com.[3]
Alternatives if Shelf Space Is Denied
Request drop-ship direct from Hansoh to bypass wholesaler stock, or explore government stockpiles via BARDA (biomedicalreadyresponsetoolkit.hhs.gov) for emergency use.
[1]: FDA.gov - Xphozah Approval Summary (fda.gov/drugs/resources-information-approved-drugs/xphozah)
[2]: Hansoh Pharma - Product Contact (hansohpharma.com/products/xphozah)
[3]: DrugPatentWatch.com - Xphozah Patents (drugpatentwatch.com/p/tradename/XPHOZAH)